Back

Arrest of progression of cardiac amyloidosis after chemotherapy predicts favorable outcome in patients with light-chain amyloidosis

8 November 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 1 Epidemiology, Prognosis, Outcome ESC Premium Access ESC Asia with APSC & AFC

About the speaker

Photo
Doctor Jun Koyama

Maruko Central Hospital, Ueda (Japan)

32 More presentations in this session

Presentation thumbnail
Clinical utility of stress echocardiography in remote indigenous and non-indigenous populations: a 10-year study in central Australia
Doctor S. Ratwatte (London, GB)
Abstract
Presentation thumbnail
Characterisation of right heart dysfunction in left ventricular systolic failure
Doctor H. Chen (Sydney, AU)
Abstract
Presentation thumbnail
The impact of coronary calcification on diagnostic performance of workstation CT derived fractional flow reserve - a multicentre experience
Ms M. Isa (Melbourne, AU)
Abstract Slides
Presentation thumbnail
Efficacy and safety of catheter ablation combined with left atrial appendage occlusion in patients with atrial fibrillation over one year: first results in a Chinese population
Mr F. Xiao (Wenzhou, CN)
Presentation thumbnail
Novel use of CHA2DS2VASC score to select patients to undergo repeat atrial fibrillation screening
Doctor W. Sun (Shatin, HK)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1

The Event

Event poster

ESC Asia with APSC & AFC

8 November 2019 14:00 CET
You may be interested in
thumbnail
Congress Session
Cardiac amyloidosis: when translational approaches and personalised medicine become reality
13 May 2024
thumbnail
Congress Presentation
Mortality & inpatient hospitalizations amongst patients with cardiac light-chain amyloidosis: results from a US administrative claims database
20 June 2025
thumbnail
Congress Presentation
functional capacity assessment of cardiac amyloidosis patients before treatment and rehabilitation
13 June 2025
thumbnail
Congress Presentation
Treatment response in light chain cardiac amyloidosis improves left ventricular arterial coupling.
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources